Australia markets close in 4 hours 49 minutes

Elicio Therapeutics, Inc. (ELTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.41-0.44 (-4.97%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 86.37M
Enterprise value 81.19M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)17.74
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-15.05%
S&P500 52-week change 326.14%
52-week high 324.39
52-week low 32.96
50-day moving average 38.56
200-day moving average 37.00

Share statistics

Avg vol (3-month) 361.37k
Avg vol (10-day) 373.03k
Shares outstanding 510.27M
Implied shares outstanding 610.28M
Float 85.42M
% held by insiders 129.51%
% held by institutions 14.04%
Shares short (30 Apr 2024) 485.36k
Short ratio (30 Apr 2024) 41.45
Short % of float (30 Apr 2024) 41.06%
Short % of shares outstanding (30 Apr 2024) 40.83%
Shares short (prior month 28 Mar 2024) 439.52k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 302 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-98.95%
Return on equity (ttm)-1,288.17%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -39.18M
Net income avi to common (ttm)-38.99M
Diluted EPS (ttm)-3.82
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.85M
Total cash per share (mrq)1.15
Total debt (mrq)13.66M
Total debt/equity (mrq)280.47%
Current ratio (mrq)2.37
Book value per share (mrq)0.47

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A